Two Cases of Massive Fraud–Anesthesiology–Psychiatry
Two major cases of medical fraud have undermined patient safety and the integrity of the medico-scientific literature: But how each specialty responded is a study in contrast.
ADHD Drugs Induce Hallucinations in Kids–FDA safety Officers
Three years have elapsed since FDA medical officers reported the findings of their comprehensive review of clinical trial data at an FDA pediatric advisory committee hearing (March, 2006).
Deaths, A Consequence of Forced Psychotropic Drugs
"Whatever powers the Constitution has granted our government, involuntary mind control is not one of them, absent extraordinary circumstances." 1979, Judge Joseph L. Tauro
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
FDA Requires Added Warnings on ADHD drugs_Sweden’s “Gillberg Affair”
What does the "Gillberg affair" suggest about the integrity of the data underlying the DAMP-ADHD hypothesis?
SEC Filings: Eli Lilly Admits Problems Getting Liability Insurance For Zyprexa
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller.
Lilly -Zyprexa Casualties-$1.2 Billion Settlements-More Casualties_NYT_WSJ
Eli Lilly's latest Zyprexa settlement will not affect civil or criminal investigations pending over Zyprexa from state attorneys general and federal prosecutors, which are continuing.
Lilly Marketing Zyprexa Challenged by Stat AGs–NYT_Antipsychotics: Off-label Use
State Attorney Generals are investigating the off-label marketing of Zyprexa–which, if documented is a federal crime.
AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics
"Most off-label use occurs without scientific support."
Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYT
The New York Times reports that internal marketing documents show that “Eli Lilly encouraged primary care physicians to use Zyprexa, in patients who did not have either condition.”
DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USE
THE NEW YORK TIMES EXPOSE OF ELI LILLY SECRET ZYPREXA DOCUMENTS Part II.
Assaultive Prescribing of Psych Drugs for Children
Australian psychiatrist: "Does anyone else see tardive dysmentia after atypicalantipsychotics?"
U.S. Doctors are prescribing the antidepressant, Effexor (150mg) for infants under age one!